Keyphrases
Meropenem
100%
Septic Shock
100%
Dosing Regimen
100%
Continuous Infusion
40%
Baumannii
40%
Pseudomonas Aeruginosa (P. aeruginosa)
40%
Normal Renal Function
20%
Creatinine Clearance
20%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
20%
Pharmacokinetics
20%
Population Pharmacokinetics
20%
Targeted Therapy
20%
Prolonged Infusion
20%
Pseudomonas Aeruginosa Infection
20%
Dosing Recommendations
20%
EudraCT
20%
Monte Carlo Simulation
20%
Blood Samples
20%
Renal Function
20%
Adult Patients
20%
MS Method
20%
Large Cohort
20%
Dose Rate
20%
Targeted Treatment
20%
Acinetobacter Baumannii (A. baumannii)
20%
Pharmacology, Toxicology and Pharmaceutical Science
Septic Shock
100%
Meropenem
100%
Pharmacokinetic
40%
Pseudomonas aeruginosa
40%
Acinetobacter Baumannii
20%
High Performance Liquid Chromatography
20%
Pseudomonas Infection
20%
Drug Concentration
20%
Creatinine
20%